BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19932479)

  • 1. Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention.
    Balestrieri ML; Lu SJ; de Nigris F; Giovane A; Williams-Ignarro S; D'Armiento FP; Feng Q; Fiorito C; Testa G; Pastore L; Cacciatore F; Mancini FP; Servillo L; De Rosa G; Pagliarulo C; Rienzo M; Minucci PB; Farzati B; Salvatore F; Rengo F; Ignarro LJ; Giordano A; Baker A; Lanza R; Napoli C
    Atherosclerosis; 2010 Apr; 209(2):403-14. PubMed ID: 19932479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
    de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb.
    Sica V; Williams-Ignarro S; de Nigris F; D'Armiento FP; Lerman LO; Balestrieri ML; Maione C; Palagiano A; Rossiello L; Ignarro LJ; Napoli C
    Cell Cycle; 2006 Dec; 5(24):2903-8. PubMed ID: 17172874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb.
    de Nigris F; Williams-Ignarro S; Sica V; D'Armiento FP; Lerman LO; Byrns RE; Sica G; Fiorito C; Ignarro LJ; Napoli C
    Int J Cardiol; 2007 Apr; 117(2):238-43. PubMed ID: 16875745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.
    Napoli C; Williams-Ignarro S; de Nigris F; de Rosa G; Lerman LO; Farzati B; Matarazzo A; Sica G; Botti C; Fiore A; Byrns RE; Sumi D; Sica V; Ignarro LJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17202-6. PubMed ID: 16286655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
    Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
    Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.
    Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ
    Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of simvastatin and/or antioxidant vitamins in therapeutic angiogenesis in experimental diabetic hindlimb ischemia: effects on capillary density, angiogenesis markers, and oxidative stress.
    El-Azab MF; Hazem RM; Moustafa YM
    Eur J Pharmacol; 2012 Sep; 690(1-3):31-41. PubMed ID: 22705060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
    Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
    Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
    Rokutanda T; Izumiya Y; Miura M; Fukuda S; Shimada K; Izumi Y; Nakamura Y; Araki S; Hanatani S; Matsubara J; Nakamura T; Kataoka K; Yasuda O; Kaikita K; Sugiyama S; Kim-Mitsuyama S; Yoshikawa J; Fujita M; Yoshiyama M; Ogawa H
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2872-80. PubMed ID: 21940947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.
    Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U
    Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells.
    Cheng Z; Garikipati VN; Nickoloff E; Wang C; Polhemus DJ; Zhou J; Benedict C; Khan M; Verma SK; Rabinowitz JE; Lefer D; Kishore R
    Circulation; 2016 Nov; 134(19):1467-1483. PubMed ID: 27660293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
    Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
    Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia.
    Iwase T; Nagaya N; Fujii T; Itoh T; Ishibashi-Ueda H; Yamagishi M; Miyatake K; Matsumoto T; Kitamura S; Kangawa K
    Circulation; 2005 Jan; 111(3):356-62. PubMed ID: 15655128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol.
    Gan L; Matsuura H; Ichiki T; Yin X; Miyazaki R; Hashimoto T; Cui J; Takeda K; Sunagawa K
    Hypertens Res; 2009 Jul; 32(7):542-7. PubMed ID: 19444278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.